Athrombogenic coating of long-term venous catheter for cancer patients: A prospective, randomised, double-blind trial

Annals of Hematology

Volumn 91, Issue 4, 2012, Pages 613-620

  Hitz, Felicitas ^a   Klingbiel, Dirk ^c   Omlin, Aurelius ^a   Riniker, Salomé ^a   Zerz, Andreas ^b   Cerny, Thomas ^a  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^b Chirurgische Klinik Stadtspital Waid   (Switzerland)

^c SWISS GROUP FOR CLINICAL CANCER RESEARCH SAKK   (Switzerland)

Author keywords

Athrombogenic layer; Cancer; Central venous catheter; Coated; Infection; Venous thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTHRACYCLINE; CISPLATIN; FLUOROURACIL; GEMCITABINE; LOW MOLECULAR WEIGHT HEPARIN; STEROID; TAXANE DERIVATIVE; UROKINASE; ANTINEOPLASTIC AGENT; BIOMATERIAL;

ADSORPTION; ADULT; AGED; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CATHETER COMPLICATION; CATHETER INFECTION; CATHETER THROMBOSIS; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DOUBLE BLIND PROCEDURE; FEMALE; GYNECOLOGIC CANCER; HEMATOLOGIC MALIGNANCY; HEMATOMA; HUMAN; INTRAVENOUS CATHETER; LOGISTIC REGRESSION ANALYSIS; LONG TERM CARE; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MATERIAL COATING; MELANOMA; OUTCOME ASSESSMENT; PNEUMOTHORAX; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK REDUCTION; SARCOMA; THROMBOGENICITY; THROMBOSIS PREVENTION; THYMUS; THYMUS CANCER; UROGENITAL TRACT CANCER; VENOUS THROMBOEMBOLISM; ARTICLE; CENTRAL VENOUS CATHETERIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; INDWELLING CATHETER; INSTRUMENTATION; MIDDLE AGED; NEOPLASM; THROMBOEMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CATHETERIZATION, CENTRAL VENOUS; CATHETERS, INDWELLING; COATED MATERIALS, BIOCOMPATIBLE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; THROMBOEMBOLISM; YOUNG ADULT;

EID: 84860813879     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-011-1343-8     Document Type: Review

References (23)

1. Vescia S, Baumgartner AK, Jacobs VR, Kiechle-Bahat M, Rody A, Loibl S et al (2008) Management of venous port systems in oncology: a review of current evidence. Ann Oncol 19(1):9-15
2. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW et al (2004) Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(3 Suppl):338S-400S
3. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd (2000) Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 160(6):809-815
4. Sallah S, Wan JY, Nguyen NP (2002) Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb Haemost 87(4):575-579
5. Thodiyil PA, Kakkar AK (2002) Variation in relative risk of venous thromboembolism in different cancers. Thromb Haemost 87(6):1076-1077
6. Saphner T, Tormey DC, Gray R (1991) Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol 9(2):286-294
7. Levine MN, Gent M, Hirsh J, Arnold A, Goodyear MD, Hryniuk Wet al (1988) The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. N Engl J Med 318(7):404-407
8. Yildizeli B, Lacin T, Batirel HF, Yuksel M (2004) Complications and management of long-term central venous access catheters and ports. J Vasc Access 5(4):174-178
9. De Cicco M, Matovic M, Balestreri L, Panarello G, Fantin D, Morassut S et al (1997) Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study. Thromb Res 86(2):101-113
10. Pottecher T, Forrler M, Picardat P, Krause D, Bellocq JP, Otteni JC (1984) Thrombogenicity of central venous catheters: prospective study of polyethylene, silicone and polyurethane catheters with phlebography or post-mortem examination. Eur J Anaesthesiol 1(4):361-365
11. Xiang DZ, Verbeken EK, Van Lommel AT, Stas M, De Wever I (1998) Composition and formation of the sleeve enveloping a central venous catheter. J Vasc Surg 28(2):260-271
12. Martin C, Viviand X, Saux P, Gouin F (1999) Upper-extremity deep vein thrombosis after central venous catheterization via the axillary vein. Crit Care Med 27(12):2626-2629
13. Mehall JR, Saltzman DA, Jackson RJ, Smith SD (2002) Fibrin sheath enhances central venous catheter infection. Crit Care Med 30(4):908-912
14. Clopper CJ, Pearson ES (1934) The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26:404-413
15. Cook RJSD (1995) The number needed to treat: a clinically useful measure of treatment effect. BMJ 310:452-454
16. Lyon RD, Griggs KA, Johnson AM, Olsen JR (1999) Long-term follow-up of upper extremity implanted venous access devices in oncology patients. J Vasc Interv Radiol 10(4):463-471
17. Lokich JJ, Bothe A Jr, Benotti P, Moore C (1985) Complications and management of implanted venous access catheters. J Clin Oncol 3(5):710-717
18. Tesselaar ME, Ouwerkerk J, Nooy MA, Rosendaal FR, Osanto S (2004) Risk factors for catheter-related thrombosis in cancer patients. Eur J Canc 40(15):2253-2259
19. Boersma RS, Jie KS, Verbon A, van Pampus EC, Schouten HC (2008) Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies. Ann Oncol 19(3):433-442
20. van Rooden CJ, Rosendaal FR, Barge RM, van Oostayen JA, van der Meer FJ, Meinders AE et al (2003) Central venous catheter related thrombosis in haematology patients and prediction of risk by screening with Doppler-ultrasound. Br J Haematol 123(3):507-512
21. Karthaus M, Kretzschmar A, Kroning H, Biakhov M, Irwin D, Marschner N et al (2006) Dalteparin for prevention of catheterrelated complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Ann Oncol 17(2):289-296
22. Bern MM, Lokich JJ, Wallach SR, Bothe A Jr, Benotti PN, Arkin CF (1990) Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 112(6):423-428
23. Monreal M, Alastrue A, Rull M, Mira X, Muxart J, Rosell R et al (1996) Upper extremity deep venous thrombosis in cancer patients with venous access devices-prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 75(2):251-253